Change search
Link to record
Permanent link

Direct link
Bentinger, Magnus
Publications (4 of 4) Show all publications
Surmacz, L., Wojcik, J., Kania, M., Bentinger, M., Danikiewicz, W., Dallner, G., . . . Swiezewska, E. (2015). Short-chain polyisoprenoids in the yeast Saccharomyces cerevisiae - New companions of the old guys. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1851(10), 1296-1303
Open this publication in new window or tab >>Short-chain polyisoprenoids in the yeast Saccharomyces cerevisiae - New companions of the old guys
Show others...
2015 (English)In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, ISSN 1388-1981, E-ISSN 1879-2618, Vol. 1851, no 10, p. 1296-1303Article in journal (Refereed) Published
Abstract [en]

Dolichols are, among others, obligatory cofactors of protein glycosylation in eukaryotic cells. It is well known that yeast cells accumulate a family of dolichols with Dol-15/16 dominating while upon certain physiological conditions a second family with Dol-21 dominating is noted. In this report we identified the presence of additional short-chain length polyprenols - all-trans Pren-7 in three yeast strains (SS328, BY4741 and L5366), Pren-7 was accompanied by traces of putative Pren-6 and -8. Moreover, in two of these strains a single polyprenol mainly-cis-Pren-11 was synthesized at the stationary phase of growth. Identity of polyprenols was confirmed by HR-HPLC/MS, NMR and metabolic labeling. Additionally, simvastatin inhibited their biosynthesis.

Keywords
Polyisoprenoid alcohols, Dolichol, Prenol, Saccharomyces cerevisiae, yeast
National Category
Biological Sciences
Identifiers
urn:nbn:se:su:diva-121859 (URN)10.1016/j.bbalip.2015.06.006 (DOI)000361403100002 ()26143379 (PubMedID)
Available from: 2015-10-26 Created: 2015-10-19 Last updated: 2022-02-23Bibliographically approved
Bentinger, M., Kania, M., Danikiewicz, W., Kaczorowska, E., Wojcik, J., Brismar, K., . . . Tekle, M. (2014). Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1841(7), 977-986
Open this publication in new window or tab >>Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis
Show others...
2014 (English)In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, ISSN 1388-1981, E-ISSN 1879-2618, Vol. 1841, no 7, p. 977-986Article in journal (Refereed) Published
Abstract [en]

2,3-Oxidosqualene is an intermediate in cholesterol biosynthesis and 2,3:22,23-dioxidosqualene act as the substrate for an alternative pathway that produces 24(S),25-epoxycholesterol which effects cholesterol homeostasis. In light of our previous findings concerning the biological effects of certain epoxidated all-trans-polyisoprenes, the effects of squalene carrying epoxy moieties on the second and third isoprene residues were investigated here. In cultures of HepG2 cells both monoepoxides of squalene and one of their hydrolytic products inhibited cholesterol synthesis and stimulated the synthesis of coenzyme Q (CoQ). Upon prolonged treatment the cholesterol content of these cells and its labeling with [H-3]mevalonate were reduced, while the amount and labeling of CoQ increased. Injection of the squalene monoepoxides into mice once daily for 6 days elevated the level of CoQ in their blood, but did not change the cholesterol level. The same effects were observed upon treatment of apoE-deficient mice and diabetic GK-rats. This treatment increased the hepatic level of CoQ10 in mice, but the amount of CoQ9, which is the major form, was unaffected. The presence of the active compounds in the blood was supported by the finding that cholesterol synthesis in the white blood cells was inhibited. Since the ratio of CoQ9/CoQ10 varies depending on the experimental conditions, the cells were titrated with substrate and inhibitors, leading to the conclusion that the intracellular isopentenyl-PP pool is a regulator of this ratio. Our present findings indicate that oxidosqualenes may be useful for stimulating both the synthesis and level of CoQ both in vitro and in vivo.

Keywords
Mevalonate pathway, Squalene epoxides, Coenzyme Q induction, Cholesterol inhibition, Dolichol
National Category
Biochemistry and Molecular Biology
Identifiers
urn:nbn:se:su:diva-105884 (URN)10.1016/j.bbalip.2014.03.007 (DOI)000336698800007 ()
Funder
Swedish Research Council, K2014-55X-22514-01-3
Note

AuthorCount:10;

Available from: 2014-07-09 Created: 2014-07-08 Last updated: 2022-02-23Bibliographically approved
Bentinger, M., Tekle, M., Dallner, G., Brismar, K., Gustafsson, J.-Å., Steffensen, K. R. & Sergiu-Bogdan, C. (2012). Influence of liver-X-receptor on tissue cholesterol, coenzyme Q and dolichol content. Paper presented at 52nd International Conference on the Bioscience of Lipids - Expanding the Horizons of Lipidomics, Warsaw, Poland, August 30 - September 03, 2011. Molecular membrane biology, 29(7), 299-308
Open this publication in new window or tab >>Influence of liver-X-receptor on tissue cholesterol, coenzyme Q and dolichol content
Show others...
2012 (English)In: Molecular membrane biology, ISSN 0968-7688, E-ISSN 1464-5203, Vol. 29, no 7, p. 299-308Article in journal (Refereed) Published
Abstract [en]

The organ content of the mevalonate pathway lipids was investigated in liver-X-receptor (LXR) alpha, beta and double knockout mice. An extensive or moderate increase of total cholesterol in the double KO mice was found in all organs elicited by the increase of the esterified form. In LXR alpha and double KO mice, coenzyme Q (CoQ) was decreased in liver and increased in spleen, thymus and lung, while dolichol was increased in all organs investigated. This effect was confirmed using LXR-agonist GW 3965. Analysis of CoQ distribution in organelles showed that the modifications are present in all cellular compartments and that the increase of the lipid in mitochondria was the result of a net increase of CoQ without changing the number of mitochondria. It appears that LXR influences not only cellular cholesterol homeostasis but also the metabolism of CoQ and dolichol, in an indirect manner.

Keywords
Liver-X-receptor, coenzyme Q, cholesterol, dolichol, membrane modification
National Category
Biochemistry and Molecular Biology
Identifiers
urn:nbn:se:su:diva-83014 (URN)10.3109/09687688.2012.694484 (DOI)000310315200009 ()
Conference
52nd International Conference on the Bioscience of Lipids - Expanding the Horizons of Lipidomics, Warsaw, Poland, August 30 - September 03, 2011
Note

AuthorCount:7;

Available from: 2012-12-05 Created: 2012-12-03 Last updated: 2022-02-24Bibliographically approved
Bentinger, M., Tekle, M. & Dallner, G. (2010). Coenzyme Q - Biosynthesis and functions. Biochemical and Biophysical Research Communications - BBRC, 396(1), 74-79
Open this publication in new window or tab >>Coenzyme Q - Biosynthesis and functions
2010 (English)In: Biochemical and Biophysical Research Communications - BBRC, ISSN 0006-291X, E-ISSN 1090-2104, Vol. 396, no 1, p. 74-79Article in journal (Refereed) Published
Abstract [en]

In addition to its role as a component of the mitochondrial respiratory chain and our only lipid-soluble antioxidant synthesized endogenously, in recent years coenzyme Q (CoQ) has been found to have an increasing number of other important functions required for normal metabolic processes. A number of genetic mutations that reduce CoQ biosynthesis are associated with serious functional disturbances that can be eliminated by dietary administration of this lipid, making CoQ deficiencies the only mitochondrial diseases which can be successfully treated at present. In connection with certain other diseases associated with excessive oxidative stress, the level of CoQ is elevated as a protective response. Aging, certain experimental conditions and several human diseases reduce this level, resulting in serious metabolic disturbances. Since dietary uptake of this lipid is limited, up-regulation of its biosynthetic pathway is of considerable clinical interest. One approach for this purpose is administration of epoxidated all-trans polyisoprenoids, which enhance both CoQ biosynthesis and levels in experimental systems.

Keywords
Coenzyme Q, Mevalonate pathway, Metabolic regulators, Mitochondrial diseases
National Category
Biochemistry and Molecular Biology
Identifiers
urn:nbn:se:su:diva-49914 (URN)10.1016/j.bbrc.2010.02.147 (DOI)000278251800015 ()
Note
authorCount :3Available from: 2010-12-21 Created: 2010-12-20 Last updated: 2022-02-24Bibliographically approved
Organisations

Search in DiVA

Show all publications